Home Applications 200045 Application 200045
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE TABLET;ORAL EQ 150MG BASE;EQ 5MG BASE;12.5MG No No 002 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE TABLET;ORAL EQ 300MG BASE;EQ 5MG BASE;12.5MG No No 003 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE TABLET;ORAL EQ 300MG BASE;EQ 5MG BASE;25MG No No 004 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE TABLET;ORAL EQ 300MG BASE;EQ 10MG BASE;12.5MG No No 005 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE TABLET;ORAL EQ 300MG BASE;EQ 10MG BASE;25MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N200045-001 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 N200045-002 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 N200045-003 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 N200045-004 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 N200045-005 AMTURNIDE ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 4 of 6 · 215 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2020-12-22 03:56 UTC 2020-12 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N200045-001 AMTURNIDE EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N200045-002 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N200045-003 AMTURNIDE EQ 300MG BASE;EQ 5MG BASE;25MG TABLET / ORAL 2010-12-21 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N200045-004 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET / ORAL 2010-12-21 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N200045-005 AMTURNIDE EQ 300MG BASE;EQ 10MG BASE;25MG TABLET / ORAL 2010-12-21 ea1830bbd6c7…
Observed Orange Book patent history# Patent history page 1 of 5 · 165 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.